capable of normalizing neuronal calcium dyshomeostasis. Also disclosed are methods comprising these compounds for treating neuronal or neurological disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, fronto-temporal dementia, Pick's disease, chronic traumatic encepholopathy, traumatic brain injury, stroke, cerebellar ataxia, multiple sclerosis, Down syndrome, and aging-related CNS disorders."/>
公开/公告号US9725429B2
专利类型
公开/公告日2017-08-08
原文格式PDF
申请/专利号US201514716138
申请日2015-05-19
分类号C07D307/54;C07D405/12;C07D307/52;C07D407/12;
国家 US
入库时间 2022-08-21 13:42:48